Tg Therapeutics (TGTX) Current Assets (2010 - 2026)
Tg Therapeutics (TGTX) posted quarterly Current Assets of $1.1 billion for Q1 2026, up 68.65% year-over-year from $644.5 million in Q1 2025, and up 72.33% quarter-over-quarter from $630.8 million in Q4 2025.
Tg Therapeutics (TGTX) Current Assets (2010 - 2026) Analysis & Trends
Tg Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- In Q1 2026, Current Assets rose 68.65% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 68.65% YoY), while the FY2025 annual figure was $630.8 million, up 11.37% from the prior year.
- Current Assets for Q1 2026 stood at $1.1 billion, up from $630.8 million in the prior quarter.
- The five-year high for Current Assets was $1.1 billion in Q1 2026, with the low at $168.3 million in Q4 2022.
- The 5-year median for Current Assets is $360.6 million (2024), against an average of $431.9 million.
- The sharpest annual moves came in 2022 and 2024: Current Assets slumped 55.49% in 2022, then jumped 95.14% in 2024.
- Tg Therapeutics' Current Assets stood at $168.3 million in 2022, then jumped by 88.94% to $317.9 million in 2023, then jumped by 78.13% to $566.4 million in 2024, then rose by 11.37% to $630.8 million in 2025, then jumped by 72.33% to $1.1 billion in 2026.
- Business Quant data shows TGTX's Current Assets at $1.1 billion in Q1 2026, $630.8 million in Q4 2025, and $599.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 1.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Bn |
| Mar 31, 2026 | 1.09 Bn |
| Dec 31, 2025 | 630.76 Mn |
| Sep 30, 2025 | 599.77 Mn |
| Jun 30, 2025 | 663.96 Mn |
| Mar 31, 2025 | 644.51 Mn |
| Dec 31, 2024 | 566.36 Mn |
| Sep 30, 2024 | 574.07 Mn |
| Jun 30, 2024 | 389.15 Mn |
| Mar 31, 2024 | 360.58 Mn |
| Dec 31, 2023 | 317.94 Mn |
| Sep 30, 2023 | 319.11 Mn |
| Jun 30, 2023 | 208.57 Mn |
| Mar 31, 2023 | 184.78 Mn |
| Dec 31, 2022 | 168.27 Mn |
| Sep 30, 2022 | 182.92 Mn |
| Jun 30, 2022 | 202.56 Mn |
| Mar 31, 2022 | 242.22 Mn |
| Dec 31, 2021 | 330.97 Mn |
| Sep 30, 2021 | 371.78 Mn |